HR+ HER2- Breast Cancer


Conference Reporter in HR+ HER2- Breast Cancer to Cover Key Topics Being Presented at the 2023 ASCO Annual Meeting

conference reporter by Ian Krop, MD, PhD; Sara M. Tolaney, MD, MPH


Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Breast Cancer presented at this year’s ASCO Annual Meeting.


  • CDK4/6 Inhibition in Early-Stage and Advanced HR+ Breast Cancer
  • HR+ Breast Cancer—Local/Regional/Adjuvant Therapy Updates
  • HR+/HER2- Breast Cancer: Conference Highlights
  • SERMs and SERDs in Breast Cancer: Where Do We Stand?


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology. 

Ian Krop, MD, PhD

Professor of Internal Medicine, Section of Medical Oncology
Associate Cancer Center Director, Clinical Research
Chief Clinical Research Officer
Yale Cancer Center
Yale School of Medicine
New Haven, CT

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician
Dana-Farber Cancer Institute
Associate Professor, Department of Medicine
Harvard Medical School
Boston, MA